Status:
COMPLETED
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
Lead Sponsor:
Astellas Pharma Inc
Collaborating Sponsors:
Astellas Pharma US, Inc.
Conditions:
Psoriasis
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis.
Eligibility Criteria
Inclusion
- Clinical diagnosis of plaque psoriasis
Exclusion
- Skin disorder other than plaque psoriasis in the areas to be treated.
- Disease on only elbows, knees, and scalp
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
658 Patients enrolled
Trial Details
Trial ID
NCT00293891
End Date
January 1 2007
Last Update
December 24 2007
Active Locations (33)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States, 35205
2
Little Rock, Arkansas, United States, 72205
3
San Diego, California, United States, 92123
4
Denver, Colorado, United States, 80246